Arcadia Biosciences
RKDA
Arcadia Biosciences (RKDA) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $7 M
According to Arcadia Biosciences's latest financial reports the company's total liabilities are $7 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Arcadia Biosciences - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $8.02 M | -36.94% |
| 2021-12-31 | $12.72 M | -32.32% |
| 2020-12-31 | $18.79 M | -22.48% |
| 2019-12-31 | $24.24 M | 116.33% |
| 2018-12-31 | $11.2 M | 30.9% |
| 2017-12-31 | $8.56 M | -75.09% |
| 2016-12-31 | $34.37 M | 1.06% |
| 2015-12-31 | $34.01 M | -68.98% |
| 2014-12-31 | $0.10 B | 308.57% |
| 2013-12-31 | $26.83 M | 40.94% |
| 2012-12-31 | $19.04 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Codexis
CDXS | $49.94 M | 613.31% | 🇺🇸 USA |
 ScottsMiracle-Gro SMG | $4.10 B | 58,476.12% | 🇺🇸 USA |
 American Vanguard AVD | $0.39 B | 5,577.49% | 🇺🇸 USA |